{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T03:46:26Z","timestamp":1768016786468,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81200170"],"award-info":[{"award-number":["81200170"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671934"],"award-info":[{"award-number":["81671934"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Heart failure is associated with ventricular dyssynchrony and energetic inefficiency, which can be alleviated by cardiac resynchronization therapy (CRT) with approximately one-third of non-response rate. Thus far, there is no specific biomarker to predict the response to CRT in patients with heart failure. In this study, we assessed the role of the blood metabolomic profile in predicting the response to CRT.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>A total of 105 dilated cardiomyopathy patients with severe heart failure who received CRT were included in our two-stage study. Baseline blood samples were collected prior to CRT implantation. The response to CRT was defined according to echocardiographic criteria. Metabolomic profiling of serum samples was carried out using ultrahigh performance liquid chromatography coupled with quadrupole-time-of-flight mass spectrometry.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Seventeen metabolites showed significant differences in their levels between responders and non-responders, and these metabolites were primarily involved in six pathways, including linoleic acid metabolism, Valine, leucine and isoleucine biosynthesis, phenylalanine metabolism, citrate cycle, tryptophan metabolism, and sphingolipid metabolism. A combination of isoleucine, tryptophan, and linoleic acid was identified as an ideal metabolite panel to distinguish responders from non-responders in the discovery set (<jats:italic>n<\/jats:italic>\u00a0=\u200951 with an AUC of 0.981), and it was confirmed in the validation set (<jats:italic>n<\/jats:italic>\u00a0=\u200954 with an AUC of 0.929).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Mass spectrometry based serum metabolomics approach provided larger coverage of metabolome which can help distinguish CRT responders from non-responders. A combination of isoleucine, tryptophan, and linoleic acid may associate with significant prognostic values for CRT.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12872-020-01443-y","type":"journal-article","created":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T12:02:50Z","timestamp":1587038570000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Circulating metabolite profiles to predict response to cardiac resynchronization therapy"],"prefix":"10.1186","volume":"20","author":[{"given":"Xue","family":"Gong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhonghan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheyong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziqing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenqi","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixiu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengmei","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangang","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junbo","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,16]]},"reference":[{"key":"1443_CR1","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J. 2016;37:2129\u2013200.","journal-title":"Eur Heart J"},{"key":"1443_CR2","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1016\/j.jacc.2004.08.016","volume":"44","author":"JJ Bax","year":"2004","unstructured":"Bax JJ, Bleeker GB, Marwick TH, Molhoek SG, Boersma E, Steendijk P, et al. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol. 2004;44:1834\u201340.","journal-title":"J Am Coll Cardiol"},{"key":"1443_CR3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2459\/JCM.0000000000000635","volume":"19","author":"B Sassone","year":"2018","unstructured":"Sassone B, Nucifora G, Mele D, Valzania C, Bisignani G, Boriani G, et al. Role of cardiovascular imaging in cardiac resynchronization therapy: a literature review. J Cardiovasc Med (Hagerstown). 2018;19:211\u201322.","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"1443_CR4","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.amjcard.2014.10.024","volume":"115","author":"B Sassone","year":"2015","unstructured":"Sassone B, Gambetti S, Bertini M, Beltrami M, Mascioli G, Bressan S, et al. Relation of QRS duration to response to cardiac resynchronization therapy. Am J Cardiol. 2015;115:214\u20139.","journal-title":"Am J Cardiol"},{"key":"1443_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0217875","volume":"14","author":"AM Suszko","year":"2019","unstructured":"Suszko AM, Nayyar S, Porta-Sanchez A, Das M, Pinter A, Crystal E, et al. Quantification of abnormal QRS peaks predicts response to cardiac resynchronization therapy and tracks structural remodeling. PLoS One. 2019;14:e0217875.","journal-title":"PLoS One"},{"key":"1443_CR6","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s13238-018-0549-0","volume":"9","author":"Z Wang","year":"2018","unstructured":"Wang Z, Zhao Y. Gut microbiota derived metabolites in cardiovascular health and disease. Protein Cell. 2018;9:416\u201331.","journal-title":"Protein Cell"},{"key":"1443_CR7","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nrm.2016.25","volume":"17","author":"CH Johnson","year":"2016","unstructured":"Johnson CH, Ivanisevic J, Siuzdak G. Metabolomics: beyond biomarkers and towards mechanisms. Nat Rev Mol Cell Biol. 2016;17:451\u20139.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1443_CR8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.aca.2018.04.006","volume":"1037","author":"M Yan","year":"2018","unstructured":"Yan M, Xu G. Current and future perspectives of functional metabolomics in disease studies-a review. Anal Chim Acta. 2018;1037:41\u201354.","journal-title":"Anal Chim Acta"},{"key":"1443_CR9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2459\/JCM.0000000000000028","volume":"15","author":"L Padeletti","year":"2014","unstructured":"Padeletti L, Modesti PA, Cartei S, Checchi L, Ricciardi G, Pieragnolia P, et al. Metabolomic does not predict response to cardiac resynchronization therapy in patients with heart failure. J Cardiovasc Med (Hagerstown). 2014;15:295\u2013300.","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"1443_CR10","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.cardfail.2015.04.005","volume":"21","author":"E Nemutlu","year":"2015","unstructured":"Nemutlu E, Zhang S, Xu YZ, Terzic A, Zhong L, Dzeja PD, et al. Cardiac resynchronization therapy induces adaptive metabolic transitions in the metabolomic profile of heart failure. J Card Fail. 2015;21:460\u20139.","journal-title":"J Card Fail"},{"key":"1443_CR11","doi-asserted-by":"publisher","first-page":"15126","DOI":"10.1038\/srep15126","volume":"5","author":"L Guo","year":"2015","unstructured":"Guo L, Tan G, Liu P, Li H, Tang L, Huang L, et al. Three plasma metabolite signatures for diagnosing high altitude pulmonary edema. Sci Rep. 2015;5:15126.","journal-title":"Sci Rep"},{"key":"1443_CR12","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","volume":"113","author":"BJ Maron","year":"2006","unstructured":"Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association scientific statement from the council on clinical cardiology, heart failure and transplantation committee; quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups; and council on epidemiology and prevention. Circulation. 2006;113:1807\u201316.","journal-title":"Circulation."},{"key":"1443_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1471-2261-14-55","volume":"14","author":"D Rinkuniene","year":"2014","unstructured":"Rinkuniene D, Bucyte S, Ceseviciute K, Abramavicius S, Baronaite-Dudoniene K, Laukaitiene J, et al. Predictors of positive response to cardiac resynchronization therapy. BMC Cardiovasc Disord. 2014;14:55.","journal-title":"BMC Cardiovasc Disord"},{"key":"1443_CR14","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1021\/pr070183p","volume":"6","author":"HG Gika","year":"2007","unstructured":"Gika HG, Theodoridis GA, Wingate JE, Wilson ID. Within-day reproducibility of an HPLC-MS-based method for metabonomic analysis: application to human urine. J Proteome Res. 2007;6:3291\u2013303.","journal-title":"J Proteome Res"},{"key":"1443_CR15","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jpba.2019.01.022","volume":"166","author":"D Wang","year":"2019","unstructured":"Wang D, Tan G, Wang H, Chen P, Hao J, Wang Y. Identification of novel serum biomarker for the detection of acute myeloid leukemia based on liquid chromatography-mass spectrometry. J Pharm Biomed Anal. 2019;166:357\u201363.","journal-title":"J Pharm Biomed Anal"},{"key":"1443_CR16","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1039\/C1MB05324H","volume":"8","author":"G Tan","year":"2012","unstructured":"Tan G, Lou Z, Liao W, Dong X, Zhu Z, Li W, et al. Hydrophilic interaction and reversed-phase ultraperformance liquid chromatography TOF-MS for serum metabonomic analysis of myocardial infarction in rats and its applications. Mol BioSyst. 2012;8:548\u201356.","journal-title":"Mol BioSyst"},{"key":"1443_CR17","volume-title":"Metabolomic data processing, analysis, and interpretation using MetaboAnalyst. Current protocols in bioinformatics","author":"J Xia","year":"2011","unstructured":"Xia J, Wishart DS. Metabolomic data processing, analysis, and interpretation using MetaboAnalyst. Current protocols in bioinformatics. 2011; Chapter 14:Unit 14.0."},{"key":"1443_CR18","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.redox.2013.12.009","volume":"2","author":"C Asselin","year":"2014","unstructured":"Asselin C, Ducharme A, Ntimbane T, Ruiz M, Fortier A, Guertin MC, et al. Circulating levels of linoleic acid and HDL-cholesterol are major determinants of 4-hydroxynonenal protein adducts in patients with heart failure. Redox Biol. 2014;2:148\u201355.","journal-title":"Redox Biol"},{"key":"1443_CR19","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1161\/CIRCHEARTFAILURE.115.002216","volume":"8","author":"S Oka","year":"2015","unstructured":"Oka S, Zhai P, Yamamoto T, Ikeda Y, Byun J, Hsu CP, et al. Peroxisome proliferator activated receptor-alpha Association with silent information regulator 1 suppresses cardiac fatty acid metabolism in the failing heart. Circ Heart Fail. 2015;8:1123\u201332.","journal-title":"Circ Heart Fail"},{"key":"1443_CR20","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.jcmg.2011.07.006","volume":"4","author":"E Carluccio","year":"2011","unstructured":"Carluccio E, Biagioli P, Alunni G, Murrone A, Pantano P, Biscottini E, et al. Presence of extensive LV remodeling limits the benefits of CRT in patients with intraventricular dyssynchrony. JACC Cardiovasc Imaging. 2011;4:1067\u201376.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1443_CR21","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/eurjhf\/hfq003","volume":"12","author":"B Vidal","year":"2010","unstructured":"Vidal B, Delgado V, Mont L, Poyatos S, Silva E, Angeles Castel M, et al. Decreased likelihood of response to cardiac resynchronization in patients with severe heart failure. Eur J Heart Fail. 2010;12:283\u20137.","journal-title":"Eur J Heart Fail"},{"key":"1443_CR22","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1111\/pace.12971","volume":"39","author":"YZ Xu","year":"2016","unstructured":"Xu YZ, Chen CF, Chen B, Gao XF, Hua W, Cha YM, et al. The modulating effects of cardiac resynchronization therapy on myocardial metabolism in heart failure. Pacing Clin Electrophysiol. 2016;39:1404\u20139.","journal-title":"Pacing Clin Electrophysiol"},{"key":"1443_CR23","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ygeno.2009.03.003","volume":"94","author":"D Colak","year":"2009","unstructured":"Colak D, Kaya N, Al-Zahrani J, Al Bakheet A, Muiya P, Andres E, et al. Left ventricular global transcriptional profiling in human end-stage dilated cardiomyopathy. Genomics. 2009;94:20\u201331.","journal-title":"Genomics."},{"key":"1443_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1365-2796.2006.01663.x","volume":"260","author":"H Norrelund","year":"2006","unstructured":"Norrelund H, Wiggers H, Halbirk M, Frystyk J, Flyvbjerg A, Botker HE, et al. Abnormalities of whole body protein turnover, muscle metabolism and levels of metabolic hormones in patients with chronic heart failure. J Intern Med. 2006;260:11\u201321.","journal-title":"J Intern Med"},{"key":"1443_CR25","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.jacc.2015.02.018","volume":"65","author":"ML Cheng","year":"2015","unstructured":"Cheng ML, Wang CH, Shiao MS, Liu MH, Huang YY, Huang CY, et al. Metabolic disturbances identified in plasma are associated with outcomes in patients with heart failure: diagnostic and prognostic value of metabolomics. J Am Coll Cardiol. 2015;65:1509\u201320.","journal-title":"J Am Coll Cardiol"},{"key":"1443_CR26","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1365-2362.2010.02441.x","volume":"41","author":"D Alexander","year":"2011","unstructured":"Alexander D, Lombardi R, Rodriguez G, Mitchell MM, Marian AJ. Metabolomic distinction and insights into the pathogenesis of human primary dilated cardiomyopathy. Eur J Clin Investig. 2011;41:527\u201338.","journal-title":"Eur J Clin Investig"},{"key":"1443_CR27","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.metabol.2012.07.023","volume":"62","author":"WG Witham","year":"2013","unstructured":"Witham WG, Yester KA, McGaffin KR. A high leucine diet mitigates cardiac injury and improves survival after acute myocardial infarction. Metabolism. 2013;62:290\u2013302.","journal-title":"Metabolism."},{"key":"1443_CR28","first-page":"314","volume":"147","author":"E Yu","year":"2017","unstructured":"Yu E, Ruiz-Canela M, Guasch-Ferre M, Zheng Y, Toledo E, Clish CB, et al. Increases in plasma tryptophan are inversely associated with incident cardiovascular disease in the Prevencion con Dieta Mediterranea (PREDIMED) study. J Nutr. 2017;147:314\u201322.","journal-title":"J Nutr"},{"key":"1443_CR29","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1744-9987.2010.00883.x","volume":"15","author":"H Fujii","year":"2011","unstructured":"Fujii H, Nakai K, Fukagawa M. Role of oxidative stress and indoxyl sulfate in progression of cardiovascular disease in chronic kidney disease. Ther Apher Dial. 2011;15:125\u20138.","journal-title":"Ther Apher Dial"},{"key":"1443_CR30","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1253\/circj.CJ-12-0715","volume":"77","author":"S Shimazu","year":"2013","unstructured":"Shimazu S, Hirashiki A, Okumura T, Yamada T, Okamoto R, Shinoda N, et al. Association between indoxyl sulfate and cardiac dysfunction and prognosis in patients with dilated cardiomyopathy. Circ J. 2013;77:390\u20136.","journal-title":"Circ J"},{"key":"1443_CR31","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.2215\/CJN.03980609","volume":"4","author":"FC Barreto","year":"2009","unstructured":"Barreto FC, Barreto DV, Liabeuf S, Meert N, Glorieux G, Temmar M, et al. Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clin J Am Soc Nephrol. 2009;4:1551\u20138.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1443_CR32","doi-asserted-by":"publisher","first-page":"100","DOI":"10.2478\/v10039-011-0057-4","volume":"57","author":"M Knapp","year":"2012","unstructured":"Knapp M, Baranowski M, Lisowska A, Musial W. Decreased free sphingoid base concentration in the plasma of patients with chronic systolic heart failure. Adv Med Sci. 2012;57:100\u20135.","journal-title":"Adv Med Sci"},{"key":"1443_CR33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.yjmcc.2017.07.004","volume":"110","author":"A Polzin","year":"2017","unstructured":"Polzin A, Piayda K, Keul P, Dannenberg L, Mohring A, Graler M, et al. Plasma sphingosine-1-phosphate concentrations are associated with systolic heart failure in patients with ischemic heart disease. J Mol Cell Cardiol. 2017;110:35\u20137.","journal-title":"J Mol Cell Cardiol"},{"key":"1443_CR34","doi-asserted-by":"crossref","unstructured":"Keul P, van Borren MM, Ghanem A, Muller FU, Baartscheer A, Verkerk AO, et al. Sphingosine-1-phosphate receptor 1 regulates cardiac function by modulating Ca2+ sensitivity and Na+\/H+ exchange and mediates protection by ischemic preconditioning. J Am Heart Assoc. 2016;20;5:e003393.","DOI":"10.1161\/JAHA.116.003393"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-020-01443-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-020-01443-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-020-01443-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T01:06:26Z","timestamp":1618535186000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-020-01443-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,16]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1443"],"URL":"https:\/\/doi.org\/10.1186\/s12872-020-01443-y","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,16]]},"assertion":[{"value":"1 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All patients signed written informed consent form. Fudan University affiliated Zhongshan Hospital Ethics Committee had approved the work and received all the written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no competing financial interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"178"}}